As healthcare facilities across the nation deal with shortages of certain drugs, including generics, pharmacists and pharmacy managers are tasked with the daily monitoring of drug supplies and increased communications with other healthcare professionals such as nurses and physicians.
FDA has approved cholic acid (Cholbam), a once-daily treatment for pediatric and adult patients who have bile acid synthesis disorders due to single enzyme defects. It is also approved as an adjunct to standard care for patients with peroxisomal disorders, such as Zellweger spectrum disorders.
The University of Pittsburgh School of Pharmacy School has developed a website that will track drug overdoses in some Pennsylvania counties.
Most primary care physicians are aware of prescription drug monitoring programs (PMPs) designed to prevent doctor shopping, but more than four out of 10 are not using them, according to a survey published in the March issue of Health Affairs.
A pharmacy student and an industry professional offer two very different takes on the issues and what to do about them.
California pharmacist Afrouz Nikmanesh recently filed a class-action lawsuit against Walmart, alleging the retail giant cheated her and her colleagues out of work breaks and overtime pay.
Patricia C. Kienle, RPh, director of accreditation and medication safety for Cardinal Health Innovative Delivery Solutions, is urging pharmacies to begin planning to become compliant with requirements for handling hazardous drugs, specified in the United States Pharmacopeia’s (USP) draft chapter 800.
NACDS has acquired a program that trains pharmacists to administer point-of-care testing in pharmacies; it will kick off in April with a tour of pharmacy schools nationwide.
A Mississippi pharmacist has agreed to forfeit $2 million he earned through an online scheme that distributed painkillers to customers who had not received medical consultations.
Shaw’s Supermarkets is fighting an effort by a Teamsters local to represent pharmacists at its 16 stores in Maine.
The American Pharmacists Association (APhA) Foundation recently announced the 2015 recipients of its Incentive Grants for Practitioner Innovation in Pharmaceutical Care.
If you're waffling on the idea of taking out professional liability insurance, read this and think again.
Without provider status, it can take years for a pharmacist to achieve a good relationship with a medical practice.
Pharmacists must walk a careful line in the practice of ambulatory care pharmacy. Here are some things to think about.
MTM reimbursement gets a big push from the feds.
A recent ISMP study found that the government’s adverse event reporting system is hampered by incomplete reports from manufacturers.
From program launch through December 2014, CVS has sold 63% more smoking cessation products and seen 61% more Minute Clinic visits than it did during the same period a year earlier.
The country is moving toward provider status. But direct reimbursement isn't here yet.
Validation through inclusion in Medicare Part B could lead to recognition of pharmacists as healthcare providers across the board.
When consumers have to pay for their own healthcare, their first stop will be the corner drugstore. Get ready.
Children are especially vulnerable to this product, which is brightly colored and sweetened with candy-like flavors.
Ceftolozane/tazobactam was approved to treat complicated urinary tract infections and to treat - in combination with metronidazole - complicated intra-abdominal infections.
Pharmacists need to own this service. The survival of the profession may depend on it.
The nation's governors get it and have affirmed it publicly. When will the rest of the country get on board?
New study finds that AF patients under 65 years of age but with a CHA2DS2-VASc score of 1 are unlikely to benefit from anticoagulation therapy.
Time to give those babies some love.
New Rx, new generics, new OTC, new devices
Letters, e-mails, posts, and comments from Drug Topics readers
If you're Dennis Miller, the answer is a dozen more questions, and some of them are doozies.
A New Mexico state legislative committee has added a provision to an antiabortion measure that would allow pharmacists the right to not dispense abortion medication based on personal and religious beliefs.